Teradata Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Teradata Corporation on May 19, 2026, covering events occurring on May 14, 2026. The filing details the results of the Company's Annual Meeting of Stockholders and the approval of amendments to its equity incentive plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and equity plan amendments rather than financial performance data.
Material Changes and Corporate Actions
- Stock Incentive Plan Amendment: Stockholders approved the Teradata 2023 Stock Incentive Plan as Amended and Restated, increasing the number of shares available for issuance by 6,300,000 shares.
- Director Elections: Three Class I directors were elected to three-year terms expiring in 2029: Melissa B. Fisher, Stephen McMillan, and Kimberly K. Nelson.
- Executive Compensation: Stockholders cast an advisory "say-on-pay" vote in favor of executive compensation.
- Auditor Ratification: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 was ratified.
Voting Results and Management Commentary
Approximately 93.33% of total shares issued and outstanding were present or represented by proxy at the Annual Meeting. The voting outcomes were as follows:
- Director Elections: All three nominees received majority support, though Kimberly K. Nelson received the highest number of "Against" votes (7,671,249) compared to her peers.
- Say-on-Pay: Approved with 77,550,609 votes "For" versus 2,479,139 "Against."
- Amended 2023 Plan: Approved with 73,643,705 votes "For" versus 6,403,587 "Against."
- Auditor Ratification: Overwhelmingly approved with 87,449,014 votes "For" versus 638,248 "Against."
The filing does not contain specific management commentary, risk factors, or guidance beyond the procedural details of the meeting.
Investor Verification Checklist
- Verify the impact of the 6,300,000 share increase on potential future dilution.
- Review the full text of the Amended 2023 Plan (Exhibit 10.1) for specific vesting terms and eligibility criteria.
- Analyze the "Against" vote percentages for the director nominees, particularly Kimberly K. Nelson, to assess shareholder sentiment.
- Confirm the 2026 financial results in the upcoming 10-K or 10-Q filings, as this 8-K contains no financial performance data.